HIV Vaccine Research Network
What the HIV Vaccine Research Network does
The HIV Vaccine Research Network was originally known as the Global HIV Vaccine Enterprise, which became an IAS programme in 2018. The network strengthens African leadership in HIV vaccine research by supporting early- to mid-career researchers and advocates through training, mentorship and targeted capacity building. It fosters collaboration between researchers, policy makers, advocates and community leaders, and ensures that African perspectives s[JB3.1]hape the global HIV vaccine agenda.
The HIV Vaccine Research Network in context
Although multiple HIV prevention options exist, access and uptake remain uneven, and HIV incidence continues to be unacceptably high in certain regions and populations. An effective HIV vaccine remains essential to sustainably reducing transmission and preventing new HIV acquisitions. Strengthening African leadership in HIV vaccine research and equipping advocates to safeguard that science and keep communities and policy makers engaged are key to closing these gaps and ensuring that solutions are grounded in the needs and realities of the communities most affected.
The academy has strengthened my motivation to collaborate with other researchers to contribute to the growing body of African-led research that supports the development of an effective HIV vaccine.
2026 HIV Vaccine Science Academy participant
The HIV Vaccine Research Network in action
The HIV Vaccine Research Network builds capacity, fosters collaboration, enables locally driven solutions and expands support critical to advancing HIV vaccine research and leadership in Africa.
It does so by:
Building research capacity through HIV Vaccine Science Academies, virtual learning and hands-on skills training
Training advocates to champion HIV vaccine science, engage policy makers and keep communities informed about the latest developments
Supporting professional growth through structured mentorship with global HIV vaccine experts
Mobilizing knowledge via webinars and workshops that bring together scientists, policy makers, advocates and community leaders on priority HIV vaccine research and development topics
Elevating voices of African researchers and advocates through speaking and networking opportunities at major HIV conferences
Strengthening regional collaboration through active alumni networks and engagement with global experts
Key numbers
Contact
In partnership with
